213 related articles for article (PubMed ID: 19952362)
1. A DNA methyltransferase inhibitor and all-trans retinoic acid reduce oral cavity carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide.
Tang XH; Albert M; Scognamiglio T; Gudas LJ
Cancer Prev Res (Phila); 2009 Dec; 2(12):1100-10. PubMed ID: 19952362
[TBL] [Abstract][Full Text] [Related]
2. Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice.
Tang XH; Knudsen B; Bemis D; Tickoo S; Gudas LJ
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):301-13. PubMed ID: 14734483
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of lecithin:retinol acyltransferase in the epithelial basal layer makes mice more sensitive to oral cavity carcinogenesis induced by a carcinogen.
Tang XH; Su D; Albert M; Scognamiglio T; Gudas LJ
Cancer Biol Ther; 2009 Jul; 8(13):1212-3. PubMed ID: 19471114
[TBL] [Abstract][Full Text] [Related]
4. Combination of bexarotene and the retinoid CD1530 reduces murine oral-cavity carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide.
Tang XH; Osei-Sarfo K; Urvalek AM; Zhang T; Scognamiglio T; Gudas LJ
Proc Natl Acad Sci U S A; 2014 Jun; 111(24):8907-12. PubMed ID: 24927566
[TBL] [Abstract][Full Text] [Related]
5. Bitter Melon Prevents the Development of 4-NQO-Induced Oral Squamous Cell Carcinoma in an Immunocompetent Mouse Model by Modulating Immune Signaling.
Sur S; Steele R; Aurora R; Varvares M; Schwetye KE; Ray RB
Cancer Prev Res (Phila); 2018 Apr; 11(4):191-202. PubMed ID: 29061560
[TBL] [Abstract][Full Text] [Related]
6. Oral carcinogenesis induced by 4-nitroquinoline 1-oxide in lecithin:retinol acyltransferase gene knockout mice.
Liu L; Tang XH; Scognamiglio T; Gudas LJ
J Nutr Biochem; 2010 Oct; 21(10):975-82. PubMed ID: 19954945
[TBL] [Abstract][Full Text] [Related]
7. Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine.
McGregor F; Muntoni A; Fleming J; Brown J; Felix DH; MacDonald DG; Parkinson EK; Harrison PR
Cancer Res; 2002 Aug; 62(16):4757-66. PubMed ID: 12183435
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 overexpression increases susceptibility to 4-nitroquinoline-1-oxide-induced dysplasia and neoplasia in murine squamous oral epithelium.
Wilkey JF; Buchberger G; Saucier K; Patel SM; Eisenberg E; Nakagawa H; Michaylira CZ; Rustgi AK; Mallya SM
Mol Carcinog; 2009 Sep; 48(9):853-61. PubMed ID: 19263437
[TBL] [Abstract][Full Text] [Related]
9. Comparable molecular alterations in 4-nitroquinoline 1-oxide-induced oral and esophageal cancer in mice and in human esophageal cancer, associated with poor prognosis of patients.
Yang Z; Guan B; Men T; Fujimoto J; Xu X
In Vivo; 2013; 27(4):473-84. PubMed ID: 23812217
[TBL] [Abstract][Full Text] [Related]
10. Fenofibrate exhibits a high potential to suppress the formation of squamous cell carcinoma in an oral-specific 4-nitroquinoline 1-oxide/arecoline mouse model.
Chang NW; Tsai MH; Lin C; Hsu HT; Chu PY; Yeh CM; Chiu CF; Yeh KT
Biochim Biophys Acta; 2011 Apr; 1812(4):558-64. PubMed ID: 21081159
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis in rats by flavonoids diosmin and hesperidin, each alone and in combination.
Tanaka T; Makita H; Ohnishi M; Mori H; Satoh K; Hara A; Sumida T; Fukutani K; Tanaka T; Ogawa H
Cancer Res; 1997 Jan; 57(2):246-52. PubMed ID: 9000563
[TBL] [Abstract][Full Text] [Related]
12. Methylation-associated gene silencing of RARB in areca carcinogens induced mouse oral squamous cell carcinoma.
Lai ZL; Tsou YA; Fan SR; Tsai MH; Chen HL; Chang NW; Cheng JC; Chen CM
Biomed Res Int; 2014; 2014():378358. PubMed ID: 25197641
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemically-induced mouse model of oral squamous cell carcinoma.
Leeman-Neill RJ; Seethala RR; Singh SV; Freilino ML; Bednash JS; Thomas SM; Panahandeh MC; Gooding WE; Joyce SC; Lingen MW; Neill DB; Grandis JR
Cancer Prev Res (Phila); 2011 Feb; 4(2):230-7. PubMed ID: 21163936
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of 4-nitroquinoline-1-oxide-induced rat oral carcinogenesis by dietary exposure of a new retinoidal butenolide, KYN-54, during the initiation and post-initiation phases.
Makita H; Tanaka T; Ohnishi M; Tamai Y; Torihara M; Yamahara J; Mori H; Satoh K; Hara A
Carcinogenesis; 1995 Sep; 16(9):2171-6. PubMed ID: 7554071
[TBL] [Abstract][Full Text] [Related]
15. The molecular features of tongue epithelium treated with the carcinogen 4-nitroquinoline-1-oxide and alcohol as a model for HNSCC.
Osei-Sarfo K; Tang XH; Urvalek AM; Scognamiglio T; Gudas LJ
Carcinogenesis; 2013 Nov; 34(11):2673-81. PubMed ID: 23784083
[TBL] [Abstract][Full Text] [Related]
16. Placental glutathione S-transferase correlates with cellular proliferation during rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide.
Silva RN; Ribeiro DA; Salvadori DM; Marques ME
Exp Toxicol Pathol; 2007 Sep; 59(1):61-8. PubMed ID: 17596925
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary curcumin and hesperidin: comparison with the protective effect of beta-carotene.
Tanaka T; Makita H; Ohnishi M; Hirose Y; Wang A; Mori H; Satoh K; Hara A; Ogawa H
Cancer Res; 1994 Sep; 54(17):4653-9. PubMed ID: 8062259
[TBL] [Abstract][Full Text] [Related]
18. STAT3 as a Chemoprevention Target in Carcinogen-Induced Head and Neck Squamous Cell Carcinoma.
Peyser ND; Wang L; Zeng Y; Acquafondata M; Freilino M; Li H; Sen M; Gooding WE; Satake M; Wang Z; Johnson DE; Grandis JR
Cancer Prev Res (Phila); 2016 Aug; 9(8):657-63. PubMed ID: 27267892
[TBL] [Abstract][Full Text] [Related]
19. Valproic acid, in combination with all-trans retinoic acid and 5-aza-2'-deoxycytidine, restores expression of silenced RARbeta2 in breast cancer cells.
Mongan NP; Gudas LJ
Mol Cancer Ther; 2005 Mar; 4(3):477-86. PubMed ID: 15767557
[TBL] [Abstract][Full Text] [Related]
20. Oral mucosal carcinogenesis in SENCAR mice.
Kim TW; Chen Q; Shen X; Regezi JA; Ramos DM; Tanaka H; Jordan RC; Kramer RH
Anticancer Res; 2002; 22(5):2733-40. PubMed ID: 12529989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
